In this program we discuss the determination of how specific patient
factors can help with the individualization of antihyperglycemic therapies
Individualizing of Antihyperglycemic Agents in Type 2 Diabetes – Specialists
CAN-eng
$0
gratuit
MOC - Section 1
15 minutes
Endocrinology
0.25 Credits
Description du cours
Détails du cours
Date d'expiration : 2020-11-26
Métiers: Spécialiste
Faculté
| David C.W. Lau (MD, PhD, FRCPC) David Strain (MB, ChB, BSc (Hons) MD, FRCP) Deanna Telner (MD, CCFP) Elizabeth Rosolowsky (MD, MPH, FAAP, FRCPC) Jeffrey Habert (MD, CCFP, FCFP) John Axler (MD, CCFP, FCFP) Peter J. Lin (MD, CCFP) Robyn L. Houlden (MD, FRCPC) Thomas Round (MBBS, BSc, DRCOG, MRCGP) |
Accréditation
This event is an accredited group learning activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program. It is approved by the Canadian Society of Endocrinology and Metabolism for a maximum of 0.25 credit(s).
Objectif(s) d'apprentissage
Upon completion of this program, participants will be able to:
1. Customize quickly and easily antihyperglycemic therapy for patients